{"id":"CHEMBL1064","canonicalSmiles":"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21","inchiKey":"RYMZZMVNJRMUDD-HGQWONQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMVASTATIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flolipid","Lacersa","Ranzolont","Simvador","Simvastatin","Zocor","Zocor heart-pro"],"synonyms":["C10AA01","MK-0733","MK-733","Simvastatin","Simvastatin hydroxy acid","Synvinolin"],"crossReferences":{"DailyMed":["simvastatin"],"PubChem":["144204247","144210718","164339438","170464984","496592","50086525"],"TG-GATEs":["117"],"Wikipedia":["Simvastatin"],"drugbank":["DB00641"],"chEBI":["9150"]},"count":91,"approvedIndications":["HP_0003124","EFO_0000712","HP_0003119","EFO_0000319","EFO_0003774","EFO_0000612","EFO_0001360","EFO_0004911"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0021118","EFO_0001361","EFO_0007486","EFO_0000275","EFO_0000249","EFO_0000401","EFO_0004698","EFO_1001951","EFO_0003914","HP_0100543","EFO_0008585","EFO_0002690","MONDO_0008903","EFO_0003884","EFO_1000652","EFO_1002032","EFO_0000400","EFO_0000407","MONDO_0002635","EFO_0002618","MONDO_0005149","HP_0012532","EFO_0004197","EFO_0000666","MONDO_0008315","EFO_0000660","EFO_0001663","EFO_0001422","EFO_1001231","EFO_0000574","EFO_0007328","EFO_0001378","EFO_0000341","EFO_0005672","EFO_0003086","EFO_0007405","MONDO_0007254","Orphanet_586","EFO_0008568","MONDO_0001056","EFO_0000289","EFO_0009854","EFO_0004319","Orphanet_648","EFO_0001645","EFO_0003929","EFO_0000319","EFO_0001073","EFO_0004911","EFO_0000537","EFO_0000195","EFO_0003885","EFO_0004268","EFO_1001121","EFO_0000649","EFO_0000764","Orphanet_79211","EFO_0000702","MONDO_0043510","EFO_0005411","EFO_0004265","EFO_0004264","MONDO_0002009","EFO_1000657","EFO_0005669","EFO_0003774","EFO_0000266","EFO_1001898","EFO_0004208","EFO_0000692","EFO_0008522","EFO_0009441","HP_0003124","HP_0001685","EFO_0002508","EFO_0003821","EFO_1001466","MONDO_0008170","HP_0001919","Orphanet_309005","HP_0100806","MP_0001845","MONDO_0100096","EFO_0004192","EFO_0000731","EFO_0000270","EFO_0001359","EFO_0001360","EFO_0006834","Orphanet_232","EFO_0000464","EFO_0003876","EFO_1002048","EFO_0000305","MONDO_0001187","EFO_0004211","EFO_1001480","EFO_0000474","EFO_1001375","EFO_0003144","EFO_0000712","HP_0003119","EFO_1001343","Orphanet_180","EFO_0000685","HP_0002140","EFO_0009783","EFO_0003770","EFO_0003060","EFO_0000311","EFO_0003106","EFO_0000589","EFO_0000713","EFO_0000095","EFO_0008583","EFO_0000612","Orphanet_818"],"count":117},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 8 approved and 83 investigational indications."}
{"id":"CHEMBL1079576","canonicalSmiles":"NC(=O)OCCCc1ccccc1","inchiKey":"CAMYKONBWHRPDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENPROBAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MH-532","Phenprobamate"],"crossReferences":{"PubChem":["144205768","170465902","26758011","49674599"],"Wikipedia":["Phenprobamate"],"drugbank":["DB13354"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1085","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2","inchiKey":"WNTYBHLDCKXEOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOPHENAZINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetophenazine","Tindal"],"crossReferences":{"PubChem":["50125831"],"Wikipedia":["Acetophenazine"],"drugbank":["DB01063"],"chEBI":["2401"]},"childChemblIds":["CHEMBL2360079"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and is indicated for psychosis."}
{"id":"CHEMBL1096339","canonicalSmiles":"NCCc1ccc(S(=O)(=O)F)cc1","inchiKey":"MGSKVZWGBWPBTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(2-Aminoethyl)Benzenesulfonyl Fluoride","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(2-Aminoethyl)Benzenesulfonyl Fluoride"],"crossReferences":{"PubChem":["11110786","90340895"],"Wikipedia":["AEBSF"],"drugbank":["DB07347"]},"childChemblIds":["CHEMBL1256178"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117348","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)CN21","inchiKey":"QYNUQALWYRSVHF-ABLWVSNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLITIXORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Folitixorin"],"crossReferences":{"Wikipedia":["5,10-Methylenetetrahydrofolate"],"chEBI":["20502"]},"childChemblIds":["CHEMBL2103811"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1199080","canonicalSmiles":"CC[N+](C)(C)Cc1ccccc1Br","inchiKey":"AAQOQKQBGPPFNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRETYLIUM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bretylium"],"crossReferences":{"DailyMed":["bretylium%20tosylate"],"PubChem":["50113154","50113155"],"Wikipedia":["Bretylium"],"drugbank":["DB01158"],"chEBI":["3172"]},"childChemblIds":["CHEMBL1095292"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL1200387","canonicalSmiles":"CC(N)Cc1ccccc1.O=C(O)CCCCC(=O)O","inchiKey":"OFCJKOOVFDGTLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPHETAMINE ADIPATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amphetamine adipate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975."}
{"id":"CHEMBL1200399","canonicalSmiles":"Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1","inchiKey":"RICLFGYGYQXUFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUSPIRONE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL49","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buspar","Buspirone hydrochloride"],"synonyms":["APD-405","APD405","Buspirone hydrochloride","MJ 9022-1","MJ-9022-1"],"crossReferences":{"DailyMed":["buspirone%20hydrochloride"],"PubChem":["11533010","50105965","56422091"],"chEBI":["3224"]},"count":6,"approvedIndications":["EFO_0006788"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0006788","EFO_1001919","EFO_0004888","EFO_0000692","EFO_0005411"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for anxiety disorder and has 5 investigational indications."}
{"id":"CHEMBL1200412","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1","inchiKey":"UBWXUGDQUBIEIZ-QNTYDACNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANDROLONE PHENPROPIONATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Durabolin","Nandrolone phenpropionate"],"synonyms":["Nandrolone phenpropionate","Nandrolone phenylpropionate","Norandrostenolone phenylpropionate","Nortestosterone furanpropionate","Nortestosterone phenylpropionate"],"crossReferences":{"PubChem":["144206893","170465193"],"drugbank":["DB00984"],"chEBI":["7468"]},"count":1,"approvedIndications":["EFO_0003966"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003966"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for eye disease."}
{"id":"CHEMBL1200483","canonicalSmiles":"CC1NCCOC1c1ccccc1.Cl","inchiKey":"VJNXVAVKCZJOFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENMETRAZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201208","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Preludin"],"synonyms":["Phenmetraline hydrochloride","Phenmetrazine chloride","Phenmetrazine hydrochloride"],"crossReferences":{"PubChem":["144205719","170465166"],"chEBI":["8068"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200515","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"CVBMAZKKCSYWQR-WCGOZPBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESERPIDINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Harmonyl"],"synonyms":["Deserpidine","Recanescin"],"crossReferences":{"PubChem":["144206199","144206653","50113288"],"Wikipedia":["Deserpidine"],"drugbank":["DB01089"],"chEBI":["27478"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for hypertension."}
{"id":"CHEMBL1200587","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=C(O)/C=C\\C(=O)O","inchiKey":"ZYSCHNVPUOSLNC-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCHLORPERAZINE MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL728","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prochlorperazine Maleate","Procomp"],"synonyms":[],"crossReferences":{"PubChem":["26719782","50125685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200600","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"FAOZLTXFLGPHNG-KNAQIMQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROMETHOLONE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluaton","Fluor-op","Fml forte","Fml fte","Fml-neo","Oxylone"],"synonyms":["Fluorometholone","NSC-33001"],"crossReferences":{"DailyMed":["fluorometholone"],"PubChem":["144203991","144212910","170464629","56422125","855588","91286"],"Wikipedia":["Fluorometholone"],"drugbank":["DB00324"],"chEBI":["31625"]},"count":6,"approvedIndications":["MP_0001845","EFO_0009552","EFO_0003894","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0007957","MP_0001845","EFO_1000906","HP_0009926","EFO_0009552","EFO_0003894","EFO_0005752"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1200672","canonicalSmiles":"Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1.[Na+]","inchiKey":"RIWWMGQFMUUYIY-ALLHVENQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPIRAMIDE SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201204","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefpiramide sodium","Sepatren"],"synonyms":["Cefpiramide sodium","WY-44,635 SODIUM","WY-44635"],"crossReferences":{"chEBI":["31377"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200783","canonicalSmiles":"Cl.NCCNCCNCCN","inchiKey":"XPVOJYDIBHYVFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIENTINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL609","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Syprine"],"synonyms":[],"crossReferences":{"PubChem":["8139974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200810","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C[C@@H](O)C[C@@H]1O","inchiKey":"HKXBNHCUPKIYDM-CGMHZMFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXERCALCIFEROL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doxercalciferol","Hectorol"],"synonyms":["Doxercalciferol","GZ427397","TSA-840"],"crossReferences":{"DailyMed":["doxercalciferol"],"PubChem":["144206531"],"Wikipedia":["Doxercalciferol"],"drugbank":["DB06410"],"chEBI":["4712"]},"count":5,"approvedIndications":["EFO_0003884","EFO_0005754"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001173","EFO_0003884","EFO_0000676","MONDO_0008315","EFO_0005754"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for chronic kidney disease and parathyroid disease and has 3 investigational indications."}
{"id":"CHEMBL1200947","canonicalSmiles":"CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl","inchiKey":"BLWNYSZZZWQCKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIPRANOLOL HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1291","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Opthalmic toxicity"],"year":1990},"tradeNames":["Metipranolol","Optipranolol"],"synonyms":["Metipranolol HCl","Metipranolol hydrochloride"],"crossReferences":{"chEBI":["34845"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989. It was withdrawn in United Kingdom  in 1990 due to Opthalmic toxicity."}
{"id":"CHEMBL1200993","canonicalSmiles":"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]","inchiKey":"REEUVFCVXKWOFE-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLAMINE TRIETHIODIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL360055","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzcurine Iodide","Flaxedil","Gallomone Triethiodide","Relaxan"],"synonyms":["Gallamine triethiodide","Gallamone triethiodide"],"crossReferences":{"PubChem":["144205593","170465398","50106346","57264265"],"Wikipedia":["Gallamine_triethiodide"],"drugbank":["DB00483"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201023","canonicalSmiles":"Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl","inchiKey":"UQZKYYIKWZOKKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORPHENADRINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL900","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biorphen","Disipal"],"synonyms":["Orphenadrine (chloride)","Orphenadrine Chloride","Orphenadrine HCl","Orphenadrine hydrochloride"],"crossReferences":{"PubChem":["144212244","26752324","50106731","56422385","855661"],"chEBI":["60902"]},"count":1,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000103546","ENSG00000136546","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000161509","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000176884","ENSG00000196639","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for parkinson's disease."}
{"id":"CHEMBL1201302","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O","inchiKey":"VQODGRNSFPNSQE-CXSFZGCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE PHOSPHORIC ACID","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dexamethasone phosphate","Dexamethasone phosphoric acid"],"crossReferences":{"DailyMed":["dexamethasone%20sodium%20phosphate"],"chEBI":["68637"]},"childChemblIds":["CHEMBL1200637","CHEMBL2021430"],"count":6,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000845","EFO_0010822","MONDO_0017634","EFO_0004274","MONDO_0002959","EFO_0005558","EFO_0005773","EFO_0008997","EFO_0000565","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0002506","EFO_0009560","EFO_0002690","EFO_0004255","EFO_0000676","EFO_0009552","EFO_0004276","EFO_1001250","EFO_0004719","HP_0003072","EFO_0005854","EFO_1000811","EFO_0009449","EFO_0001642","EFO_1000906","EFO_1000039","HP_0001742","HP_0001873","EFO_0000384","EFO_1001119","MP_0001845","HP_0003040","EFO_1000049","Orphanet_90794","EFO_0000270","EFO_0000574","EFO_1001051","HP_0012424","EFO_0001378","EFO_1001896","EFO_0001059","MONDO_0003005","EFO_0007405","EFO_1000997","EFO_0005319","EFO_1001205","EFO_1000764","EFO_1001435","MONDO_0001280","HP_0001094","EFO_0003778","EFO_1000684","EFO_0009509","EFO_0000274","HP_0001915","HP_0004398","MONDO_0001718","EFO_1000694","EFO_0005752","EFO_0007490","EFO_0009609","Orphanet_797","EFO_0000685","MONDO_0015128","EFO_0003898","EFO_0000556","EFO_0003929","EFO_0001358","EFO_0003894","EFO_0003843","EFO_1000941","EFO_0002609","EFO_0006738","EFO_0003106","EFO_0007257","EFO_0007403","EFO_1001194","EFO_0007141","EFO_0004265","EFO_0003956"],"count":83},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 6 investigational indications."}
{"id":"CHEMBL1201891","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C","inchiKey":"FBHSPRKOSMHSIF-GRMWVWQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFLAZACORT","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcort","Emflaza","Zamene"],"synonyms":["Deflazacort","MDL 458","MDL-458","MDL458"],"crossReferences":{"DailyMed":["deflazacort"],"PubChem":["144206059","144211732","170466610"],"drugbank":["DB11921"]},"count":5,"approvedIndications":["Orphanet_98896"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","EFO_0003086","Orphanet_263","EFO_1001216","Orphanet_268","EFO_0001421","EFO_0003884","EFO_0007140","Orphanet_45448"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for duchenne muscular dystrophy and has 4 investigational indications."}
{"id":"CHEMBL1206212","canonicalSmiles":"O=C(O)COc1ccc(-c2cnc(CNC(=O)Nc3ncc(Sc4ccccn4)s3)[nH]2)cc1","inchiKey":"SSXCWVOQWRUMGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1206212","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08657"]},"childChemblIds":["CHEMBL242241"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1206869","canonicalSmiles":"O=S(=O)(O)c1ccc2cc(S(=O)(=O)O)ccc2c1","inchiKey":"FITZJYAVATZPMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1206869","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04640"],"chEBI":["41070"]},"childChemblIds":["CHEMBL319726"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213353","canonicalSmiles":"CC[N+]1(CC)CCC(=C(c2ccccc2)c2ccccc2)C1C.[Br-]","inchiKey":"UCGJZJXOPSNTGZ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIFINIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1229214","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PDB","Prifinium bromide","Pyrodifenium bromide"],"crossReferences":{"PubChem":["144206846"],"Wikipedia":["Prifinium_bromide"],"chEBI":["32052"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1221699","canonicalSmiles":"C=CC(=O)Nc1ccc2ncnc(Nc3ccccc3)c2c1","inchiKey":"JGWHILNNHLDARR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221699","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234004","canonicalSmiles":"[Li+]","inchiKey":"HBBGRARXTFLTSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LITHIUM ION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01356"],"chEBI":["49713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234087","canonicalSmiles":"O=C1Nc2ccc(-c3cnco3)cc2/C1=C/Nc1ccc2c(c1)CS(=O)(=O)C2","inchiKey":"FTQYGMLRLRXBPT-IDUWFGFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234087","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236394","canonicalSmiles":"O=C(O)CC(CC(=O)O)C(=O)O","inchiKey":"KQTIIICEAUMSDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICARBALLYLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4252467","69020"],"drugbank":["DB04562"],"chEBI":["45969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1240","canonicalSmiles":"CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C.[Br-]","inchiKey":"XLBIBBZXLMYSFF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANTHELINE BROMIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1180725","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pro-banthine","Propantheline bromide"],"synonyms":["Propantheline Bromide","Propantheline bromide"],"crossReferences":{"DailyMed":["propantheline%20bromide"],"PubChem":["144204817","144212648","170464881","26747652","50106913","56422773","855578"],"Wikipedia":["Propantheline_bromide"]},"count":1,"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["EFO_0004253","EFO_1000781"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and has 1 investigational indication."}
{"id":"CHEMBL1275868","canonicalSmiles":"CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1","inchiKey":"ZKFQEACEUNWPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELNIDIPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azelnidipine"],"crossReferences":{"PubChem":["144205993","170465756","174006618","50112690"],"drugbank":["DB09230"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1289779","canonicalSmiles":"CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl","inchiKey":"VMZUTJCNQWMAGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etizolam"],"crossReferences":{"PubChem":["144206484"],"Wikipedia":["Etizolam"],"drugbank":["DB09166"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL142703","canonicalSmiles":"N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2","inchiKey":"SYOKIDBDQMKNDQ-XWTIBIIYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILDAGLIPTIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galvus"],"synonyms":["LAF 237","LAF-237","LAF237","NVP-LAF 237","NVP-LAF237","Vildagliptin"],"crossReferences":{"Wikipedia":["Vildagliptin"],"drugbank":["DB04876"]},"count":6,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["HP_0100543","EFO_0004593","EFO_1001459","EFO_1001121","EFO_0001359","EFO_0001360","EFO_0000400","EFO_0002546"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL14376","canonicalSmiles":"COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1","inchiKey":"XMXHEBAFVSFQEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ILOPERIDONE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fanapt","Iloperidone"],"synonyms":["HP 873","HP-873","Iloperidone"],"crossReferences":{"DailyMed":["iloperidone"],"PubChem":["124899318","144207159","170465198"],"Wikipedia":["Iloperidone"],"drugbank":["DB04946"],"chEBI":["65173"]},"count":4,"approvedIndications":["EFO_0005407","EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002009","EFO_0001421","EFO_0000677","EFO_0005407","EFO_0001358","EFO_0005411","EFO_0000692"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for schizophrenia and psychosis and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1460","canonicalSmiles":"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1","inchiKey":"BXZVVICBKDXVGW-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIDANOSINE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Didanosine","Videx","Videx ec"],"synonyms":["BMY-40900","Ddi","Didanosine","Didanosine system suitability mixture","Dideoxyinosine (ddi)","NSC-612049","Videx"],"crossReferences":{"DailyMed":["didanosine"],"PubChem":["144205285","144209531","144210892","170464863","17389541","26719672","26754510","26757698","29215491","49718183"],"Wikipedia":["Didanosine"],"drugbank":["DB00900"],"chEBI":["490877"]},"count":6,"approvedIndications":["EFO_0000764","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for hiv infection and viral disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1527147","canonicalSmiles":"CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1.NCCCC[C@H](N)C(=O)O","inchiKey":"JEJFWWFZAQBZMJ-GVKMLHTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1527147","maximumClinicalTrialPhase":0,"parentId":"CHEMBL191413","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217726"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1597","canonicalSmiles":"OCC(S)CS","inchiKey":"WQABCVAJNWAXTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMERCAPROL","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anti-Lewisite","B.a.l.","Sulfactin"],"synonyms":["Bal","Dimercaprol"],"crossReferences":{"DailyMed":["dimercaprol"],"PubChem":["144203565"],"Wikipedia":["Dimercaprol"],"drugbank":["DB06782"],"chEBI":["64198"]},"childChemblIds":["CHEMBL1968682"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946."}
{"id":"CHEMBL1609891","canonicalSmiles":"CCCC[S+](=N)([O-])CC[C@H](N)C(=O)O","inchiKey":"WDFRNLYXRQXXFS-CVSPRKDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTHIONINE SULFOXIMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buthionine sulfoximine","L-Buthionine(S,R)-Sulfoximine","L-Buthionine-Sulfoximine","NSC-381100"],"crossReferences":{"PubChem":["90341329"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1614709","canonicalSmiles":"Cc1cc(Nc2ncc(F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc1N1CCN(C)CC1","inchiKey":"KSOVGRCOLZZTPF-QMKUDKLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENISERTIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-703569","R-763"],"crossReferences":{"drugbank":["DB06347"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1618279","canonicalSmiles":"Cc1nc(Nc2ccc(F)cc2)nc(N2CCc3ccccc3C2C)c1C","inchiKey":"LECZXZOBEZITCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVAPRAZAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Revaprazan","SB-641257","YH-1885 FREE BASE"],"childChemblIds":["CHEMBL1257753"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1645462","canonicalSmiles":"Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12","inchiKey":"LUJZZYWHBDHDQX-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AC-480","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-480","AC480","Ac-480","BMS-599626","Bms 599626"],"crossReferences":{"drugbank":["DB12318"]},"count":3,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000326","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1664","canonicalSmiles":"CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1","inchiKey":"MLBVMOWEQCZNCC-OEMFJLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAMPRENAVIR","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fosamprenavir","GW-433908","GW433908","GW433908A"],"crossReferences":{"DailyMed":["fosamprenavir%20calcium"],"Wikipedia":["Fosamprenavir"],"drugbank":["DB01319"],"chEBI":["82941"]},"childChemblIds":["CHEMBL2106751","CHEMBL1200734"],"count":4,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for viral disease and has 3 investigational indications."}
{"id":"CHEMBL1697835","canonicalSmiles":"Cc1c(-c2ccccc2)n(/N=N/n2c(-c3ccccc3)c(C)[n+]3ccccc23)c2cccc[n+]12.[Br-].[Br-]","inchiKey":"LBOZSXSPRGACHC-NFOZGECASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FAZADINIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1739746","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AH 8165D","Fazadinium bromide"],"crossReferences":{"drugbank":["DB13745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1741040","canonicalSmiles":"CCCC[C@@H](NC(=O)[C@@H](Cc1cn(C(=O)OC)c2ccccc12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C(=O)O","inchiKey":"LPAHKJMGDSJDRG-DJYQTOCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BQ 788","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bq 788"],"childChemblIds":["CHEMBL1515091"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1742985","drugType":"Antibody","blackBoxWarning":false,"name":"ANRUKINZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anrukinzumab","IMA-638"],"count":2,"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000270"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743088","drugType":"Antibody","blackBoxWarning":false,"name":"VELTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HA20","IMMU-106","Veltuzumab"],"count":8,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0007160","EFO_0000220","EFO_0000095","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_0005952"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1746","canonicalSmiles":"O=C([O-])CCCc1ccccc1.[Na+]","inchiKey":"VPZRWNZGLKXFOE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHENYLBUTYRATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1469","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambutyrate","Ammonaps","Buphenyl","Pheburane","Sodium phenylbutyrate"],"synonyms":["ACER-001","AMX-0035 COMPONENT SODIUM PHENYLBUTYRATE","AMX0035 COMPONENT SODIUM PHENYLBUTYRATE","NSC-657802","Sodium phenylbutyrate"],"crossReferences":{"DailyMed":["sodium%20phenylbutyrate"],"PubChem":["170465108","507865"],"Wikipedia":["Sodium_phenylbutyrate"],"chEBI":["75316"]},"count":13,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 13 investigational indications."}
{"id":"CHEMBL174984","canonicalSmiles":"COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC","inchiKey":"RGVPOXRFEPSFGH-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL174984","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Tretoquinol"],"drugbank":["DB13692"]},"childChemblIds":["CHEMBL1788290"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1766582","canonicalSmiles":"Cl.Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21","inchiKey":"RQHSAIGGUWVOBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-1487","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1230122","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-1487"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL181886","canonicalSmiles":"CC(=O)C(=O)[O-].[Na+]","inchiKey":"DAEPDZWVDSPTHF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRUVATE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1162144","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyruvate sodium","Sodium 2-Oxo-Propionate","Sodium 2-Oxopropanoate"],"crossReferences":{"PubChem":["144211803"],"Wikipedia":["Sodium_pyruvate"],"chEBI":["50144"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL189464","canonicalSmiles":"NC(=O)[C@@H]1C[C@@]2(NC(=O)NC2=O)c2cc(F)ccc2O1","inchiKey":"WAAPEIZFCHNLKK-QPUJVOFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S,R)-FIDARESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02101"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908906","canonicalSmiles":"CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)cc2)cc1","inchiKey":"NCWZOASIUQVOFA-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBETABEN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Florbetaben"],"crossReferences":{"DailyMed":["florbetaben%20f-18"]},"childChemblIds":["CHEMBL566752"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 2 investigational indications."}
{"id":"CHEMBL203266","canonicalSmiles":"COc1ccc(CN2CCNCC2)c(OC)c1OC","inchiKey":"UHWVSEOVJBQKBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETAZIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vastarel","Vastarel mr"],"synonyms":["40045","Trimetazidine","Trimetazidine hydrochloride"],"crossReferences":{"PubChem":["11112605","56423815"],"Wikipedia":["Trimetazidine"],"drugbank":["DB09069"]},"childChemblIds":["CHEMBL1476337","CHEMBL3561076"],"count":6,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 5 investigational indications."}
{"id":"CHEMBL2035187","canonicalSmiles":"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1","inchiKey":"HWXVIOGONBBTBY-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PACRITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONX-0803","Pacritinib","SB-1518","SB1518","Sb-1518"],"crossReferences":{"drugbank":["DB11697"]},"count":11,"linkedTargets":{"rows":["ENSG00000096968","ENSG00000122025"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","MONDO_0044903","MONDO_0019457","MONDO_0007254","EFO_0000222","EFO_1001469","MONDO_0008315","EFO_0003060","EFO_1001951","EFO_0002430","EFO_0000565","EFO_0004251","MONDO_0100096","EFO_0000095","EFO_0000183"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL205098","canonicalSmiles":"COc1cc(Nc2ncc3ccn(-c4ccccn4)c3n2)cc(OC)c1OC","inchiKey":"YENZSPIOXMNEFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL205098","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07248"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20767","canonicalSmiles":"N=C(N)Nc1ccc(C(=O)O)cc1","inchiKey":"SXTSBZBQQRIYCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-GUANIDINO-BENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Amino(Immino)Methylaminobenzoate","4-Guanidino-Benzoic Acid","4-Guanidinobenzoic Acid"],"crossReferences":{"drugbank":["DB02459"],"chEBI":["125204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103749","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O","inchiKey":"OIRCOABEOLEUMC-GEJPAHFPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BIVALIRUDIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angiomax","Angiomax rtu","Bivalirudin","Bivalirudin in 0.9% sodium chloride"],"synonyms":["BG-8967","BG8967","Bivalirudin"],"crossReferences":{"DailyMed":["bivalirudin"],"drugbank":["DB00006"],"chEBI":["59173"]},"childChemblIds":["CHEMBL3989957"],"count":13,"approvedIndications":["EFO_1000985","MONDO_0000831","HP_0004419","HP_0001873"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001645","MONDO_0000870","EFO_0000319","EFO_0000266","HP_0001873","MP_0001914","EFO_0000713","EFO_0008585","EFO_1000985","HP_0001871","MONDO_0000831","EFO_0008583","EFO_0003907","EFO_0000612","HP_0004419","EFO_0005672"],"count":17},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL2103827","canonicalSmiles":"N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1","inchiKey":"QXWYKJLNLSIPIN-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DROXIDOPA","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Northera"],"synonyms":["DOPS","Droxidopa","L-DOPS"],"crossReferences":{"DailyMed":["droxidopa"],"drugbank":["DB06262"],"chEBI":["31524"]},"count":7,"approvedIndications":["EFO_0005252","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0003888","EFO_1001050","EFO_0005687","EFO_0002508","EFO_0005252","EFO_0000319","EFO_0005251"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for cardiovascular disease and orthostatic hypotension and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103838","canonicalSmiles":"Cc1cc(F)ccc1-c1nc(NC(CO)CO)nc2c1ccc(=O)n2-c1c(F)cccc1F","inchiKey":"ORVNHOYNEHYKJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dilmapimod","Gw-681323","SB-681323","SB681323"],"crossReferences":{"drugbank":["DB12140"]},"childChemblIds":["CHEMBL2105674"],"count":5,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0004610","EFO_0005762","EFO_0000685","EFO_0001645","EFO_0000341"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2103979","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O","inchiKey":"NZVYCXVTEHPMHE-ZSUJOUNUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"THYMALFASIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zadaxin"],"synonyms":["Thymalfasin","Thymosin alpha1","Thymosins thymalfasin"],"count":12,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2104030","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-]","inchiKey":"NCUCGYYHUFIYNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARANIDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aranidipine"],"crossReferences":{"PubChem":["124893774","144206554","170465977"],"drugbank":["DB09229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104635","canonicalSmiles":"Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C.O=S(=O)(O)NC1CCCCC1","inchiKey":"NPCNIYOIXLZTQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPHENAZONE CYCLAMATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL288470","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminophenazone cyclamate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105487","canonicalSmiles":"[S]","inchiKey":"NINIDFKCEFEMDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFUR, PRECIPITATED","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acnaveen","Acnil","Bensulfoid","Cuticura","Dome-acne","Eskamel","Liquamat","Meted","Sastid","Sulfur soap"],"synonyms":["NSC-403664","Sulfur","Sulfur compounds","Sulfur precipitated","Sulfur, pharmaceutical","Sulfur, precipitated","Sulfur, sublimed"],"crossReferences":{"chEBI":["26833"]},"count":2,"approvedIndications":["EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for acne and has 1 investigational indication."}
{"id":"CHEMBL2105961","canonicalSmiles":"CN(C)CC(CN1c2ccccc2Sc2ccccc21)N(C)C","inchiKey":"YZQNFFLGIYEXMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPROMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminopromazine","Proquamezine","Tetrameprozine"],"crossReferences":{"drugbank":["DB15596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106316","canonicalSmiles":"c1ccc(C(c2ccccc2)N2CCN(CCCC3(c4ccccc4)OCCO3)CC2)cc1","inchiKey":"LRMJAFKKJLRDLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOTARIZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dotarizine"],"crossReferences":{"drugbank":["DB06446"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106660","canonicalSmiles":"C1CNCCN1.Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O","inchiKey":"HAAJFUJFGYCCPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEFYLLINE PIPERAZINE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL70246","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Etophylate"],"synonyms":["Acefylline piperazine","Acepifylline","Piperazine theophylline ethanoate"],"count":1,"approvedIndications":["HP_0006536"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL2107489","canonicalSmiles":"NC(=S)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"UEMLYRZWLVXWRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFATHIOUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfathiocarbamide","Sulfathiourea","Sulphathiourea"],"crossReferences":{"PubChem":["144206297"],"drugbank":["DB13699"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107495","canonicalSmiles":"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1.Cl","inchiKey":"DDVJEYDLTXRYAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMAFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL277100","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," Germany"],"classes":["Hematological toxicity"," Hepatotoxicity"," Immune system toxicity"," Nephrotoxicity"],"year":1992},"tradeNames":["Omnifiox","Teflox","Teflox 400"],"synonyms":["ABBOTT-62254","Temafloxacin hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992. It was withdrawn in United States,  United Kingdom and  Germany initially in 1992 due to Hematological toxicity,  Hepatotoxicity,  Immune system toxicity and  Nephrotoxicity."}
{"id":"CHEMBL2107979","drugType":"Antibody","blackBoxWarning":false,"name":"PEXELIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5G1.1-SC","H-5G1.1 SCFV","H5G1.1 SCFV","H5G1.1 SCFV (CDR)","Pexelizumab"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0008583"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108113","drugType":"Small molecule","blackBoxWarning":false,"name":"SESAME OIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sesame oil","Sesamum indicum oil","Sesamum indicum seed oil"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108304","drugType":"Gene","blackBoxWarning":false,"name":"ALIPOGENE TIPARVOVEC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alipogene tiparvovec"],"crossReferences":{"DrugCentral":["5172"]},"count":2,"approvedIndications":["EFO_0000319"],"description":"Gene drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL2108356","drugType":"Protein","blackBoxWarning":false,"name":"PEGDINETANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-844203","CT-322","Ct-322","Pegdinetanib","VEGFR-2 INHIBITOR PEPTIDE CT-322"],"count":5,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108370","drugType":"Antibody","blackBoxWarning":false,"name":"INOLIMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Leucotac"],"synonyms":["BT-563","Inolimomab"],"count":1,"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108501","drugType":"Antibody","blackBoxWarning":false,"name":"LABETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cea-cide"],"synonyms":["HMN-14","Labetuzumab"],"count":7,"linkedTargets":{"rows":["ENSG00000105388"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","EFO_0003860","MONDO_0007254","EFO_1000657","EFO_0004142","MONDO_0021063","EFO_1001951"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108734","drugType":"Antibody","blackBoxWarning":false,"name":"FLANVOTUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["20-D-7S","20D7S","Flanvotumab","IMC-20D7S","IMC20D7S"],"count":1,"linkedTargets":{"rows":["ENSG00000107165"],"count":1},"linkedDiseases":{"rows":["EFO_0000756"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109090","drugType":"Antibody","blackBoxWarning":false,"name":"ENLIMOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-RR-0001","Enlimomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109259","drugType":"Antibody","blackBoxWarning":false,"name":"IGN-101","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IGN-101"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109408","drugType":"Antibody","blackBoxWarning":false,"name":"LAMPALIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFD","Anti-fD","FCFD-4514S","FCFD4514S","Lampalizumab","RG-7417","RG7417","anti-FACTOR-D"],"count":1,"linkedTargets":{"rows":["ENSG00000197766"],"count":1},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109501","drugType":"Antibody","blackBoxWarning":false,"name":"IGN-311","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IGN-311"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109571","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-167","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-167","Amg-167"],"count":1,"linkedTargets":{"rows":["ENSG00000167941"],"count":1},"linkedDiseases":{"rows":["HP_0000938"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109617","drugType":"Antibody","blackBoxWarning":false,"name":"HUMAX-IL8","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986253","HUMAX-IL8","Humax-il8","MDX-018"],"count":3,"linkedTargets":{"rows":["ENSG00000169429"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100096","EFO_0000673","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109665","drugType":"Antibody","blackBoxWarning":false,"name":"OCARATUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AME-133v","LY2469298","Ocaratuzumab"],"count":1,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109677","drugType":"Antibody","blackBoxWarning":false,"name":"HUJ591 111IN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUJ591","Huj591 (111in)","Huj591 111in"],"count":1,"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110588","canonicalSmiles":"CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2","inchiKey":"FJZZPCZKBUKGGU-AUSIDOKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELIGLUSTAT","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerdelga"],"synonyms":["Eliglustat","GENZ 99067","GENZ-99067"],"crossReferences":{"DailyMed":["eliglustat%20tartrate"],"drugbank":["DB09039"],"chEBI":["82752"]},"childChemblIds":["CHEMBL4297066"],"count":3,"linkedTargets":{"rows":["ENSG00000148154"],"count":1},"linkedDiseases":{"rows":["Orphanet_77259","Orphanet_355","Orphanet_77261"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 investigational indications."}
{"id":"CHEMBL2110767","canonicalSmiles":"CN(C)CCCOC1(Cc2ccccc2)CCCCCC1","inchiKey":"FYJJXENSONZJRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENCYCLANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bencyclane"],"crossReferences":{"PubChem":["170465760"],"drugbank":["DB13488"]},"childChemblIds":["CHEMBL2105930"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL211614","canonicalSmiles":"CCCC[C@@]12CCC(=O)C(Br)=C1c1ccc(O)cc1C2","inchiKey":"FTEBGBCQCYMDPH-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL211614","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07757"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL212689","canonicalSmiles":"CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1","inchiKey":"SCXSQUUTGCWHFU-WJOKGBTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL212689","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11804"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146084","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O=C(O)c1ccccc1O","inchiKey":"MAYUSTFJKJSJNC-DSXUQNDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE SALICYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinine salicylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2151439","canonicalSmiles":"O=C(N[C@@H]1CN2CCC1CC2)c1n[nH]c2ccccc12","inchiKey":"TXCYUSKWBHUVEP-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2151439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05586"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2205638","canonicalSmiles":"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl.O=S(=O)(O)O","inchiKey":"XAOZJPJZTZRRBM-VTLYIQCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAMPHENICOL SULFATE SALT","maximumClinicalTrialPhase":0,"parentId":"CHEMBL130","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chloramphenicol Sulfate Salt"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222559","canonicalSmiles":"CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1","inchiKey":"SUJUHGSWHZTSEU-FYBSXPHGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TIPRANAVIR","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aptivus"],"synonyms":["Tipranavir","U-140690"],"crossReferences":{"DailyMed":["tipranavir"],"PubChem":["144206515"],"drugbank":["DB00932"],"chEBI":["63628"]},"childChemblIds":["CHEMBL445699","CHEMBL2103936"],"count":2,"approvedIndications":["EFO_0000764","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for viral disease and hiv infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL225986","canonicalSmiles":"O=C(O)C[C@@H](O)C(=O)O","inchiKey":"BJEPYKJPYRNKOW-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-2-Hydroxysuccinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-Hydroxysuccinic Acid"],"crossReferences":{"PubChem":["8139952"],"drugbank":["DB03499"],"chEBI":["30796"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230153","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc(NCc2cc(F)cc(F)c2)cc1","inchiKey":"SRRWXMSVQYQCRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230153","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311157","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(C(=O)O[11CH3])CCN(CCc2ccccc2)CC1","inchiKey":"YDSDEBIZUNNPOB-JVVVGQRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]-CARFENTANIL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL290429","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carfentanil"],"crossReferences":{"drugbank":["DB15360"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231779","canonicalSmiles":"COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1","inchiKey":"QNZCBYKSOIHPEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"APIXABAN","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eliquis"],"synonyms":["Apixaban","BMS-562247","BMS-562247-01"],"crossReferences":{"DailyMed":["apixaban"],"PubChem":["174006823"],"Wikipedia":["Apixaban"],"drugbank":["DB06605"],"chEBI":["72296"]},"childChemblIds":["CHEMBL3526474"],"count":21,"approvedIndications":["EFO_0000275","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0003907","HP_0004419","HP_0004936"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000220","Orphanet_232","EFO_0004286","HP_0001655","EFO_0000556","EFO_0000266","EFO_0001073","HP_0001907","HP_0000083","EFO_0003911","MP_0001914","MONDO_0100096","EFO_0010680","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0003884","EFO_0005306","EFO_0004255","MONDO_0015183","EFO_0003907","EFO_1002000","HP_0004419","EFO_0000400","EFO_0005672","HP_0004936"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 7 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL231950","canonicalSmiles":"C/C(=C1/SC(=N)NC1=O)c1ccc(-c2ccc(S(N)(=O)=O)cc2)o1","inchiKey":"AKFVRSQELXTCFW-JYRVWZFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL231950","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07540"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233360","canonicalSmiles":"N[C@H]1C[C@@H](N2CCn3c(nnc3C(F)(F)F)C2)CC[C@@H]1c1cc(F)c(F)cc1F","inchiKey":"CNKRZILQBKJWDS-WMFXKJRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07072"],"chEBI":["39959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL236036","canonicalSmiles":"CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO","inchiKey":"AERBNCYCJBRYDG-KSZLIROESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHYTOSPHINGOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phytosphingosine"],"crossReferences":{"PubChem":["26756990"],"drugbank":["DB14119"],"chEBI":["46961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364653","drugType":"Antibody","blackBoxWarning":false,"name":"ANIFROLUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anifrolumab","MEDI-546"],"count":4,"linkedTargets":{"rows":["ENSG00000142166"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761","EFO_0002690","EFO_1001993"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL236573","canonicalSmiles":"CC#CCNc1ccc(S(=O)(=O)CC2(C(=O)NO)CCN(C(=O)OC(C)(C)C)CC2)cc1","inchiKey":"RXFCFGLSOUOCEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236573","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2402904","canonicalSmiles":"COC(=O)N1CCC(CN2CCC(CNC(=O)c3cccc4[nH]c(C(C)C)nc34)CC2)CC1","inchiKey":"MZOITCJKGUIQEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-954","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Felcisetrag","TAK-954","TD-8954","Tak-954","Td-8954"],"crossReferences":{"drugbank":["DB12725"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL251073","canonicalSmiles":"CC(=O)C[C@H](c1ccccc1)c1c(O)c2ccccc2oc1=O","inchiKey":"PJVWKTKQMONHTI-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-warfarin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-warfarin"],"crossReferences":{"drugbank":["DB08496"],"chEBI":["87737"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL252164","canonicalSmiles":"CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1","inchiKey":"NDAZATDQFDPQBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMINESPIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Luminespib","NVP-AUY-922","NVP-AUY922","NVP-AUY922-NX","VER-52296"],"crossReferences":{"PubChem":["124954168"],"Wikipedia":["NVP-AUY922"],"chEBI":["83656"]},"childChemblIds":["CHEMBL3137334"],"count":13,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL254857","canonicalSmiles":"O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1","inchiKey":"BFUJHVVEMMWLHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIPEXIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1991},"tradeNames":[],"synonyms":["Fipexide"],"crossReferences":{"PubChem":["11112737","49716199"],"Wikipedia":["Fipexide"],"drugbank":["DB13790"]},"childChemblIds":["CHEMBL1377408"],"count":1,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for attention deficit hyperactivity disorder. It was withdrawn in France  in 1991 due to Hepatotoxicity."}
{"id":"CHEMBL256105","canonicalSmiles":"CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1","inchiKey":"GAOZTHIDHYLHMS-KEOBGNEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONENSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Coban [as sodium salt]","Rumensin [as sodium salt]"],"synonyms":["67314","E714","Monensin"],"crossReferences":{"Wikipedia":["Monensin"],"drugbank":["DB11430"],"chEBI":["27617"]},"childChemblIds":["CHEMBL1908308"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260538","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","inchiKey":"OOLLAFOLCSJHRE-ZHAKMVSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIPRISTAL ACETATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ella","Ellaone","Esmya"],"synonyms":["CDB-2914","PGL-4001","RTI-3021-012","Ulipristal acet","Ulipristal acetate","Ulipristal acetate ","VA-2914","VA2914"],"crossReferences":{"DailyMed":["ulipristal%20acetate"],"Wikipedia":["Ulipristal_acetate"],"chEBI":["71025"]},"count":8,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MP_0001914","MONDO_0002050","EFO_0000545","MONDO_0004169","EFO_0000731","EFO_1001757","MONDO_0007254","MONDO_0001572","Orphanet_101081","HP_0001892","EFO_0003922"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 8 investigational indications."}
{"id":"CHEMBL267048","canonicalSmiles":"O=P(O)(O)C(F)(F)c1ccc(CC(Cc2ccc(C(F)(F)P(=O)(O)O)cc2)(c2ccc(F)c(F)c2)n2nnc3ccccc32)cc1","inchiKey":"BTAGTGWPDROBMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL267048","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02651"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268736","canonicalSmiles":"CCCCC(=O)O","inchiKey":"NQPDZGIKBAWPEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALERIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butane-1-carboxylic acid","Pentanoic acid"],"crossReferences":{"PubChem":["144208759","144213347","47193677"],"Wikipedia":["Valeric_acid"],"drugbank":["DB02406"],"chEBI":["17418"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270995","canonicalSmiles":"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1","inchiKey":"LTEJRLHKIYCEOX-OCCSQVGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIVANIB ALANINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-582664","BMS-582664-02","Brivanib alaninate","Brivanib l-alanine ester"],"crossReferences":{"drugbank":["DB11865"]},"childChemblIds":["CHEMBL3526472"],"count":5,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000102755","ENSG00000037280","ENSG00000160867","ENSG00000077782"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","EFO_0000182","EFO_1001951","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL273575","canonicalSmiles":"CN1Cc2c(N)cccc2C(c2ccccc2)C1","inchiKey":"XXPANQJNYNUNES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOMIFENSINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany"," France"],"classes":["Hematological toxicity"," Hepatotoxicity"],"year":1986},"tradeNames":[],"synonyms":["Nomifensine"],"crossReferences":{"PubChem":["144212072","50105261","90340560"],"Wikipedia":["Nomifensine"],"drugbank":["DB04821"],"chEBI":["116225"]},"childChemblIds":["CHEMBL1256842"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for unipolar depression. It was withdrawn in United States,  United Kingdom,  United States,  Spain,  Germany and  France initially in 1986 due to Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL28218","canonicalSmiles":"O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1","inchiKey":"RKLNONIVDFXQRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMPERIDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Impromen"],"synonyms":["Bromperidol","R 11,333","R-11333"],"crossReferences":{"PubChem":["11112600","144204116","170465873","56463221"],"Wikipedia":["Bromperidol"],"drugbank":["DB12401"]},"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0005411","EFO_0000692"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL287556","canonicalSmiles":"O=c1cc(CO)occ1O","inchiKey":"BEJNERDRQOWKJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KOJIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Hydroxy-2-(hydroxymethyl)-4-pyrone","Kojic acid"],"crossReferences":{"PubChem":["104171348","144204365","144206999","170466814","26754136"],"Wikipedia":["Kojic_acid"],"drugbank":["DB01759"],"chEBI":["43572"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288943","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C=C\\C=C\\[C@@H](SC[C@H](N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O","inchiKey":"YEESKJGWJFYOOK-IJHYULJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUKOTRIENE D4","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leukotriene d4"],"crossReferences":{"PubChem":["26756769"],"Wikipedia":["Leukotriene_D4"],"drugbank":["DB11858"],"chEBI":["28666"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292411","canonicalSmiles":"O=C(O)[C@H](O)c1ccccc1","inchiKey":"IWYDHOAUDWTVEP-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Hydroxy-Phenyl-Acetic Acid Anion","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxy-Phenyl-Acetic Acid Anion"],"crossReferences":{"PubChem":["170465573","26513819"],"drugbank":["DB02280"],"chEBI":["17656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL302715","canonicalSmiles":"NS(=O)(=O)c1ccc(C(=O)NCc2ccccc2)cc1","inchiKey":"CZKNSZUJCJHTTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL302715","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01748"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305544","canonicalSmiles":"CCc1nc(C2CC2)c(C(N)=O)n1Cc1ccc2oc(-c3ccccc3NS(=O)(=O)C(F)(F)F)c(Br)c2c1","inchiKey":"DUEWVPTZCSAMNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPRISARTAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GR-138950","Saprisartan"],"crossReferences":{"drugbank":["DB01347"]},"childChemblIds":["CHEMBL3989726"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL308333","canonicalSmiles":"CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C","inchiKey":"XJLATMLVMSFZBN-VYDXJSESSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACTINONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actinonin"],"crossReferences":{"PubChem":["50105725","50105726","50105727","90341343"],"Wikipedia":["Actinonin"],"drugbank":["DB04310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137305","canonicalSmiles":"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1.Cl","inchiKey":"RCHQNUQAHJNRBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFACTINIB HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3137331","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Defactinib hydrochloride","VS-6063","VS-6063 HYDROCHLORIDE"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL314010","canonicalSmiles":"COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC","inchiKey":"HXLAFSUPPDYFEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVANTOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevantolol"],"crossReferences":{"Wikipedia":["Bevantolol"],"drugbank":["DB01295"],"chEBI":["238698"]},"childChemblIds":["CHEMBL2106060"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL31601","canonicalSmiles":"CC(C)(C)S(=O)(=O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1","inchiKey":"UXIGZRQVLGFTOU-VQXQMPIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMIKIREN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Remikiren"],"crossReferences":{"Wikipedia":["Remikiren"],"drugbank":["DB00212"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3182320","canonicalSmiles":"C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"IYVFNTXFRYQLRP-VVSTWUKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROXERUTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flavonoid","THR","Trioxyethylrutin","Troxerutin","Vitamin p4","Z 6000","Z-6000"],"crossReferences":{"PubChem":["144205003"],"drugbank":["DB13124"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3184454","canonicalSmiles":"NCCC(=O)N1[Zn]OC(=O)[C@@H]1Cc1cnc[nH]1","inchiKey":"IGXZLYMCFZHNKW-FJXQXJEOSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184454","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206503"],"drugbank":["DB09221"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184799","canonicalSmiles":"CNC(C)(C)Cc1ccccc1.CNC(C)(C)Cc1ccccc1.O=S(=O)(O)O","inchiKey":"DNKCFBJMFIUNRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENTERMINE SULFATE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201234","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Wyamine sulfate"],"synonyms":["Mephentermine sulfate"],"crossReferences":{"PubChem":["144204052","170465271"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951."}
{"id":"CHEMBL3188551","canonicalSmiles":"Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F","inchiKey":"XTKLTGBKIDQGQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2636771","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2636771","GSK2636771","Gsk 2636771","Gsk-2636771"],"crossReferences":{"PubChem":["174006492"],"drugbank":["DB11795"]},"count":4,"linkedTargets":{"rows":["ENSG00000051382"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000503","EFO_0001378","EFO_0002617","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL32350","canonicalSmiles":"Cc1ccc2c(c1)c1c3n2CCNC3CCC1","inchiKey":"IWVRVEIKCBFZNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRLINDOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirazidol","Pirlindole"],"crossReferences":{"Wikipedia":["Pirlindole"],"drugbank":["DB09244"]},"childChemblIds":["CHEMBL1713992","CHEMBL1470001"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3250423","canonicalSmiles":"[2H]C1([2H])CCCC([2H])([2H])C1NC(=O)N(CCCl)N=O","inchiKey":"GQYIWUVLTXOXAJ-CQOLUAMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250423","maximumClinicalTrialPhase":0,"parentId":"CHEMBL514","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326082","canonicalSmiles":"C#CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)nc(F)nc21","inchiKey":"RMOYVWKKOKERSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326082","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03137"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301620","canonicalSmiles":"COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12","inchiKey":"QRPZBKAMSFHVRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMSAVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-626529","Temsavir"],"crossReferences":{"drugbank":["DB14675"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301650","canonicalSmiles":"CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O.Cl","inchiKey":"PEXPCJWLNBNBNT-AXKGEONOSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"DALBAVANCIN HYDROCHLORIDE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3301669","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dalvance","Xydalba"],"synonyms":["Dalbavancin hydrochloride"],"crossReferences":{"DailyMed":["dalbavancin%20hydrochloride"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2014."}
{"id":"CHEMBL334226","canonicalSmiles":"Cc1ccc(S(=O)(=O)N2CCC[C@@H]2C(=O)O)cc1","inchiKey":"CGPHGPCHVUSFFA-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL334226","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02752"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3348923","canonicalSmiles":"C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1","inchiKey":"VWMJHAFYPMOMGF-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MLN-2480","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB024","MLN-2480","Mln-2480","Tak 580"],"crossReferences":{"drugbank":["DB15266"]},"count":3,"linkedTargets":{"rows":["ENSG00000078061","ENSG00000157764","ENSG00000132155"],"count":3},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0021637","EFO_0002617","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL346059","canonicalSmiles":"O=c1[nH]c2ccccc2c(=O)o1","inchiKey":"TXJUTRJFNRYTHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL346059","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208523","144213375"],"drugbank":["DB11593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL346977","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccc(S(=O)(=O)N(C)C)cc21)N(C)C","inchiKey":"VWNWVCJGUMZDIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FONAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banistyl"],"synonyms":["Dimetotiazine"],"crossReferences":{"PubChem":["144206752"],"drugbank":["DB08967"]},"childChemblIds":["CHEMBL2104669"],"count":1,"approvedIndications":["EFO_0003821"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for migraine disorder."}
{"id":"CHEMBL3544908","canonicalSmiles":"CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"SGHXFFAHXTZRQM-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZATADINE MALEATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL946","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lergocil","Optimine"],"synonyms":["Azatadine maleate","SCH 10649"],"crossReferences":{"chEBI":["2947"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL3544926","drugType":"Antibody","blackBoxWarning":true,"name":"OBILTOXAXIMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anthim"],"synonyms":["ETI-204","Obiltoxaximab"],"crossReferences":{"DailyMed":["obiltoxaximab"],"DrugCentral":["5094"]},"count":1,"approvedIndications":["EFO_0000778"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2016 and is indicated for anthrax infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545002","drugType":"Small molecule","blackBoxWarning":false,"name":"MP-412","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV-412","Mp 412","Mp-412"],"count":2,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545183","canonicalSmiles":"CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O.Cl","inchiKey":"KHQMSZGKHGQUHG-WZDHWKSBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VELCALCETIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545184","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KAI-4169 HCl","Velcalcetide hydrochloride"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545193","drugType":"Small molecule","blackBoxWarning":false,"name":"MSC-2364447","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Msc-2364447"],"count":1,"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3585642","canonicalSmiles":"[2H]c1cc2c(C([2H])([2H])[2H])c([2H])n(N(c3ccncc3F)C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])c2c([2H])c1[2H]","inchiKey":"BTDHTARYCBHHPJ-VSNDFMTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3585642","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2107762","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3622820","canonicalSmiles":"N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1","inchiKey":"KTBSXLIQKWEBRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITACITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-039110","INCB039110","Incb-039110","Incb-39110","Itacitinib"],"crossReferences":{"drugbank":["DB12154"]},"childChemblIds":["CHEMBL3948879","CHEMBL3707409","CHEMBL3947131"],"count":22,"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["MONDO_0009348","MONDO_0013730","EFO_0000616","EFO_0000685","EFO_0002618","HP_0000989","EFO_0000729","MONDO_0044903","EFO_0007183","EFO_0000756","MONDO_0007254","MONDO_0044881","EFO_0004599","EFO_0003060","EFO_0000311","EFO_0004251","EFO_0000270","MONDO_0008903","EFO_0000182","MONDO_0011962","EFO_0000574","EFO_0000676","EFO_1000560","EFO_0000183","MONDO_0024880"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL369180","canonicalSmiles":"CC(=O)N(C)c1cccc(-c2nnc3ccc(-c4ccccc4)nn23)c1","inchiKey":"ALBWBHNFOJJMCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL369180","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707336","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS CARBONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous carbonate"],"crossReferences":{"DrugCentral":["4542"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL372507","canonicalSmiles":"Nc1nnc(S)s1","inchiKey":"GDGIVSREGUOIJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372507","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12348"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3747513","canonicalSmiles":"Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2","inchiKey":"RDALZZCKQFLGJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CB-5083","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cb 5083","Cb-5083"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL380331","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1","inchiKey":"LVRKQJAEQWVSCM-HAQNSBGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380331","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07687"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL380648","canonicalSmiles":"O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCCNCC1","inchiKey":"HGEPGGJUGUMFHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KU-0058948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KU-0058948"],"crossReferences":{"drugbank":["DB08058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382300","canonicalSmiles":"CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]23OC(=O)O[C@H]2[C@H](OC(=O)[C@H](O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(C)=C1C3(C)C","inchiKey":"BWKDAMBGCPRVPI-ZQRPHVBESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORTATAXEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 59-8862","BAY-59-8862","IDN 5109","IDN-5109","Ortataxel","SB-T 101131","SB-T-101131"],"crossReferences":{"drugbank":["DB11669"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3833352","canonicalSmiles":"CC1=C\\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC\\C=C\\1.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"MVTQIFVKRXBCHS-SMMNFGSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIRGINIAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stafac"],"synonyms":["SK&F 7988","Virginiamycin"],"crossReferences":{"DrugCentral":["4028"],"drugbank":["DB11476"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL393220","canonicalSmiles":"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]","inchiKey":"FQCKMBLVYCEXJB-MNSAWQCASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ATORVASTATIN CALCIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1487","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atorvastatin calcium","Lipitor"],"synonyms":["Atorvastatin calcium","Atorvastatin calcium hydrate","Atorvastatin calcium salt anhydrous","Atorvastatin calcium salt trihydrate","Atorvastatin calcium trihydrate","CI-981"],"crossReferences":{"DailyMed":["atorvastatin%20calcium"],"PubChem":["144205238","144212690","170465113"],"chEBI":["50686"]},"count":93,"approvedIndications":["HP_0003124","MONDO_0021661","EFO_0003144","EFO_0000712","HP_0003119","EFO_0003774","EFO_0000612","EFO_0000373","EFO_0004911","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0001361","EFO_0000365","EFO_0000275","EFO_0000249","EFO_0000681","EFO_0005952","EFO_1000984","EFO_0003914","EFO_0008585","EFO_0002690","EFO_0009952","EFO_0003884","EFO_0000676","EFO_0004616","EFO_1002032","EFO_1000961","EFO_0000400","MONDO_0013730","EFO_1000812","EFO_0000180","EFO_0004286","EFO_1001771","EFO_0004197","EFO_0000384","MONDO_0008315","EFO_0000660","EFO_0001422","EFO_0009426","EFO_0006818","MONDO_0000831","EFO_0007328","EFO_0001378","EFO_0000341","EFO_0005672","EFO_0004214","MONDO_0018373","EFO_0003086","HP_0000726","MONDO_0007254","EFO_0004252","EFO_0008568","EFO_0000196","MONDO_0000820","Orphanet_797","EFO_0000616","EFO_0000765","EFO_0004269","EFO_0001645","EFO_0003929","EFO_0000222","EFO_0000319","EFO_1001267","EFO_0004911","EFO_0000537","EFO_0000195","EFO_0003885","EFO_0004517","MONDO_0021661","EFO_0000649","EFO_0000764","MONDO_0011962","Orphanet_79211","EFO_0000519","EFO_0004264","EFO_0004265","EFO_0003869","EFO_0003095","EFO_0003774","EFO_0000266","EFO_0003913","EFO_0000565","EFO_0007160","EFO_0003870","EFO_0000182","EFO_0004208","HP_0003124","EFO_0002687","HP_0001919","Orphanet_3389","EFO_0004236","EFO_0004194","Orphanet_413","Orphanet_309005","HP_0002110","HP_0100806","MP_0001845","MONDO_0100096","Orphanet_412","EFO_0000270","EFO_0001359","EFO_0001360","EFO_0000668","Orphanet_232","EFO_0000318","MONDO_0002679","EFO_1001249","EFO_0000373","EFO_0000538","EFO_0004246","EFO_0004211","HP_0000083","Orphanet_68380","EFO_0000474","EFO_1001801","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0000673","EFO_1001993","HP_0003119","EFO_0003047","EFO_0007129","EFO_0008586","EFO_0000685","HP_0002140","EFO_0009783","EFO_0000556","HP_0001647","EFO_0002615","EFO_0000311","MONDO_0004782","EFO_0008583","EFO_0000612","EFO_0003918"],"count":125},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 11 approved and 82 investigational indications."}
{"id":"CHEMBL3989410","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+]","inchiKey":"UHYAQBLOGVNWNT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOMETHACIN SODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL6","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Indocin","Indomethacin sodium"],"synonyms":["Indometacin sodium","Indometacin sodium trihydrate","Indomethacin sodium","Indomethacin sodium salt trihydrate"],"count":1,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MP_0001845"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL3989803","canonicalSmiles":"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]","inchiKey":"UNZIDPIPYUMVPA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRONE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL461522","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Grecia"," Suecia"," Nepal"," Zimbabwe"," Yemen"],"classes":["Hematological toxicity"," Immune system toxicity"],"year":1975},"tradeNames":["Diprofarn","Novaldin"],"synonyms":["Dipyrone","Metamizole sodium","Metamizole sodium monohydrate","Methampyrone","NSC-73205","Noramidopyrine methanesulfonate sodium","Sulpyrine","Sulpyrine hydrate"],"count":5,"approvedIndications":["HP_0001945","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","HP_0100806","EFO_1001412","EFO_1001463","EFO_0003821","EFO_0000712","HP_0001945","HP_0003419","EFO_0003843","EFO_0003964"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever and has 3 investigational indications. It was withdrawn in United Kingdom,  United States,  Grecia,  Suecia,  Nepal,  Zimbabwe and  Yemen initially in 1975 due to Hematological toxicity and  Immune system toxicity."}
{"id":"CHEMBL3989833","canonicalSmiles":"CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"WLQZEFFFIUHSJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIPRASIDONE MESYLATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL708","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geodon"],"synonyms":["CP-88, 059-27","CP-88,059-27","CP-88059-27","CP-8805927","Ziprasidone mesylate"],"crossReferences":{"DailyMed":["ziprasidone%20mesylate"]},"count":2,"approvedIndications":["EFO_0000289"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for bipolar disorder and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL402626","canonicalSmiles":"C[C@H]1C[C@@H](C)CN(C(=O)c2cc(Br)ccc2N)C1","inchiKey":"IUPOWBZLJSPZFT-AOOOYVTPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08579"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404313","canonicalSmiles":"C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C","inchiKey":"JXSVIVRDWWRQRT-UYDOISQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASIATIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-88135"],"crossReferences":{"drugbank":["DB14054"],"chEBI":["2873"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404508","canonicalSmiles":"O=C1CCCCc2cnn3c(NC4CC4)nc(nc23)Nc2cccc(c2)N1","inchiKey":"HIJNSOUPEZHEMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08338"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404519","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12","inchiKey":"YJEJKUQEXFSVCJ-WRFMNRASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVIRIMAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevirimat","MPC-4326","PA-103001","PA-457"],"crossReferences":{"Wikipedia":["Bevirimat"],"drugbank":["DB06581"],"chEBI":["65484"]},"childChemblIds":["CHEMBL2218911"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL406117","canonicalSmiles":"N=C(N)NCCCCCCC(=O)NC(O)C(=O)NCCCCNCCCN","inchiKey":"IDINUJSAMVOPCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUSPERIMUS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gusperimus"],"crossReferences":{"Wikipedia":["Gusperimus"],"drugbank":["DB12692"]},"childChemblIds":["CHEMBL1996913","CHEMBL2356648"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL407","canonicalSmiles":"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2","inchiKey":"OFBIFZUFASYYRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUMAZENIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anexate","Flumazenil","Flumazepil","Mazicon","Romazicon"],"synonyms":["Flumazenil","Flumazepil","RO 15-1788/000","RO-15-1788","RO-151788","RO-151788000","RO-1722","RO-41-8157"],"crossReferences":{"DailyMed":["flumazenil"],"PubChem":["104171157","11111184","11114035","11532958","170464960","26719655","26752172","26752173","50104818","56422177","85231047","90341071"],"Wikipedia":["Flumazenil"],"drugbank":["DB01205"],"chEBI":["5103"]},"count":9,"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0005246","EFO_0003890","EFO_0002508","EFO_1001884","EFO_0009267","EFO_0004242","EFO_0005230","EFO_0004698","Orphanet_908","EFO_0003829"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4081711","canonicalSmiles":"CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F","inchiKey":"JKDGKIBAOAFRPJ-ZBINZKHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06650833","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-06650833"],"crossReferences":{"drugbank":["DB15143"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL411675","canonicalSmiles":"O=C([O-])c1ccccc1-c1c2cc(Br)c(=O)c(Br)c-2oc2c(Br)c([O-])c(Br)cc12.[Na+].[Na+]","inchiKey":"SEACYXSIPDVVMV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"EOSIN Y SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL376503","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eosin Y Sodium"],"crossReferences":{"PubChem":["144205876","144212469","170466832"],"Wikipedia":["Eosin_Y"],"drugbank":["DB13706"],"chEBI":["52053"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4117187","canonicalSmiles":"COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br","inchiKey":"GWCYPEHWIZXYFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MASUPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Masupirdine","SUVN-502","Suvn-502"],"crossReferences":{"drugbank":["DB06140"]},"childChemblIds":["CHEMBL4082473"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL411930","canonicalSmiles":"Cc1ccc(C)c(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1","inchiKey":"QUPXEJURIFFVSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL411930","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1","inchiKey":"AOJJSUZBOXZQNB-VTZDEGQISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EPIRUBICIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ellence","Epirubicin","NSC-256942"],"crossReferences":{"DailyMed":["epirubicin%20hydrochloride"],"Wikipedia":["Epirubicin"],"drugbank":["DB00445"],"chEBI":["47898"]},"childChemblIds":["CHEMBL1200981"],"count":20,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for neoplasm and has 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL425","canonicalSmiles":"O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O","inchiKey":"QQBDLJCYGRGAKP-FOCLMDBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLSALAZINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dipentum","Olsalazine"],"crossReferences":{"DailyMed":["olsalazine%20sodium"],"PubChem":["50125747"],"drugbank":["DB01250"]},"childChemblIds":["CHEMBL1201013"],"count":1,"linkedTargets":{"rows":["ENSG00000132170","ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003898","HP_0004798"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and has 1 investigational indication."}
{"id":"CHEMBL4297221","canonicalSmiles":"CN(C)c1ccc2c(c1)Sc1cc(N(C)C)ccc1N2.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"SPCMQFLNOVTUBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROMETHYLTHIONINE MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL549963","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lmtx"],"synonyms":["Hydromethylthionine mesylate","TRX-0237","TRX0237","Trx0237"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297300","canonicalSmiles":"CN1CCN(C(=O)C2C(C(=O)O)[C@H]3CC[C@@H]2O3)CC1","inchiKey":"JUQMLSGOTNKJKI-IZUQBHJASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LB-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LB 100","Lb-100"],"crossReferences":{"drugbank":["DB15412"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297322","canonicalSmiles":"N#Cc1cc(CN2CCC(Nc3ncnc4sc(Cl)cc34)CC2)ccc1F.O=C(O)/C=C/C(=O)O","inchiKey":"RPYIKXHIQXRXEM-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRX-08066","maximumClinicalTrialPhase":2,"parentId":"CHEMBL513994","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prx-08066"],"crossReferences":{"drugbank":["DB05607"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297341","drugType":"Unknown","blackBoxWarning":false,"name":"RM-2 GA-68","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4301788","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["68GA-RM2","68ga-rm2","BAY-86-7548","Rm-2 ga-68"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297409","canonicalSmiles":"COC(=O)c1ccc(-c2ccc(C(=O)OC)cc2)cc1","inchiKey":"BKRIRZXWWALTPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPHENYL DIMETHYL DICARBOXYLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biphenyl dimethyl dicarboxylate","Dimethyl 4,4'-biphenyldicarboxylate","Nissel"],"crossReferences":{"drugbank":["DB12475"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297464","canonicalSmiles":"CS(=O)(=O)c1ccccc1S(=O)(=O)NO","inchiKey":"RZRWBKKAFHXNEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CXL-1020","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CXL-1020","Cxl-1020"],"crossReferences":{"drugbank":["DB15326"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297487","canonicalSmiles":"CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CCCCCCNC(C)=O)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)N(C)C1=O","inchiKey":"KBARHGHBFILILC-NGIJKBHDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CRV-431","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CRV-431","CRV431","Crv-431","Crv431"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297516","canonicalSmiles":"COc1ccc2[nH]c3c(c2c1)CCN[C@]31CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4","inchiKey":"YDDMIZRDDREKEP-HWTBNCOESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LURBINECTEDIN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zepsyre","Zepzelca"],"synonyms":["Lurbinectedin","PM-01183","PM-1183","PM01183","PM1183","Pm01183"],"crossReferences":{"DailyMed":["lurbinectedin"],"drugbank":["DB12674"]},"count":15,"approvedIndications":["EFO_0000702"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for small cell lung carcinoma and has 14 investigational indications."}
{"id":"CHEMBL4297734","drugType":"Antibody","blackBoxWarning":false,"name":"CRIZANLIZUMAB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adakveo"],"synonyms":["Crizanlizumab","Crizanlizumab-tmca","NVP-LXI-262","NVP-LXI262","SEG-101","SEG101","SEL-G1","SelG1","Selg1"],"crossReferences":{"DailyMed":["crizanlizumab-tmca"]},"count":3,"linkedTargets":{"rows":["ENSG00000174175"],"count":1},"linkedDiseases":{"rows":["MONDO_0044903","MONDO_0100096","Orphanet_232","HP_0200023","Orphanet_247691"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 investigational indications."}
{"id":"CHEMBL4297743","drugType":"Antibody","blackBoxWarning":false,"name":"ELEZANUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-555","AE12-1Y-QL","Abt-555","Elezanumab","PR-1432051"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297755","drugType":"Unknown","blackBoxWarning":false,"name":"FP-1039","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FP-1039","Fp-1039","GSK-3052230","GSK3052230","Gsk3052230","HGS1036"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297814","drugType":"Unknown","blackBoxWarning":false,"name":"PRM-151","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prm-151"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297892","drugType":"Unknown","blackBoxWarning":false,"name":"ARX-788","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARX-788","ARX788","Arx-788","Arx788"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297894","drugType":"Unknown","blackBoxWarning":false,"name":"ASP-8374","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-8374","ASP8374","Asp-8374","Asp8374","PTZ-201"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297900","drugType":"Unknown","blackBoxWarning":false,"name":"AZD-4785","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4785","AZD4785","Azd-4785","Azd4785","ION-651987","ION651987","IONIS-KRAS-2.5RX"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297985","drugType":"Antibody","blackBoxWarning":false,"name":"MAGROLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hu5F9-G4","Hu5f9 g4","Hu5f9-g4","Magrolimab"],"count":7,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4298013","drugType":"Antibody","blackBoxWarning":false,"name":"ELGEMTUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elgemtumab","LJM-716","LJM716","Ljm716","NOV-6"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298069","drugType":"Enzyme","blackBoxWarning":false,"name":"POLY (ADP-RIBOSE) POLYMERASE 1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Parp-1","Poly (adp-ribose) polymerase 1"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL438497","canonicalSmiles":"NC(=O)c1ccc[n+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1","inchiKey":"JLEBZPBDRKPWTD-TURQNECASA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINAMIDE RIBOSIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicotinamide riboside"],"crossReferences":{"drugbank":["DB14933"],"chEBI":["15927"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4542506","canonicalSmiles":"[2H]c1ccc(Nc2nc(Nc3cc(C)c(C4CCNCC4)cc3OC(C)C)ncc2Cl)c(S(=O)(=O)C(C)C)c1","inchiKey":"VERWOWGGCGHDQE-WHRKIXHSSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4542506","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2403108","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4558324","canonicalSmiles":"C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1","inchiKey":"RRMJMHOQSALEJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAZERTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNS-1480","GNS1480","Lazertinib","YH-25448","YH25448","Yh25448"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL457547","canonicalSmiles":"CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1","inchiKey":"PIEUQSKUWLMALL-YABMTYFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MICAFUNGIN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mycamine"],"synonyms":["Micafungin"],"crossReferences":{"DailyMed":["micafungin%20sodium"],"drugbank":["DB01141"],"chEBI":["600520"]},"childChemblIds":["CHEMBL1237070"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 9 investigational indications."}
{"id":"CHEMBL458624","canonicalSmiles":"CCCCOc1ccc2cc(S(=O)(=O)N[C@@H](CCC(=O)O)C(=O)O)ccc2c1","inchiKey":"UAGYXJBYAFGRFR-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458624","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08105"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594272","canonicalSmiles":"Cl.Cl.N#Cc1cccc(C(NCC2CC2)c2ccc(F)c(NC(=O)c3cc(C(F)(F)F)nn3-c3cccc(CN)c3)c2)c1","inchiKey":"XFZLBLTUANGZBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEROTRALSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4594271","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCX7353.2HCl","Berotralstat hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594405","canonicalSmiles":"Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"JSBKGJUYSLVFPF-WJQUPPJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALEMETOSTAT TOSYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4597193","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valemetostat tosylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL459505","canonicalSmiles":"CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1","inchiKey":"SNFYYXUGUBUECJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAROZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rambazole"],"synonyms":["R-115866","R115866","Talarozole"],"crossReferences":{"drugbank":["DB13083"]},"count":3,"linkedTargets":{"rows":["ENSG00000095596"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000676","EFO_0003894"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL462170","canonicalSmiles":"O=C(O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O","inchiKey":"JDARUOOLJCFUOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL462170","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07265"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL468419","canonicalSmiles":"Cl.N#Cc1ccc(C2CCCc3cncn32)cc1","inchiKey":"UKCVAQGKEOJTSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADROZOLE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL9298","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGS 16949A","Fadrozole hydrochloride"],"crossReferences":{"PubChem":["144213918"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL481","canonicalSmiles":"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC","inchiKey":"UWKQSNNFCGGAFS-XIFFEERXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IRINOTECAN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Camptosar","Irinotecan"],"crossReferences":{"DailyMed":["irinotecan%20hydrochloride"],"PubChem":["124893595"],"Wikipedia":["Irinotecan"],"drugbank":["DB00762"],"chEBI":["80630"]},"childChemblIds":["CHEMBL541887","CHEMBL1200512","CHEMBL3989514"],"count":81,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_1000419","EFO_0003891","EFO_0000637","EFO_0000365","EFO_0005952","EFO_0000632","EFO_1001951","EFO_0000178","EFO_0000588","MONDO_0021633","MONDO_0002974","MONDO_0008903","EFO_1000532","EFO_0002918","EFO_0004288","EFO_0002618","MONDO_0002537","EFO_0005922","MONDO_0019465","MONDO_0018271","EFO_1001512","EFO_1001968","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_1000026","MONDO_0002691","Orphanet_398934","MONDO_0002165","EFO_1001365","EFO_0003032","EFO_0000574","EFO_1000550","EFO_0007416","MONDO_0021117","MONDO_0002129","EFO_1001465","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0044937","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0003968","MONDO_0003165","EFO_0000326","EFO_0002499","EFO_0004193","EFO_0000183","EFO_0005588","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","MONDO_0024503","Orphanet_44890","EFO_0000403","EFO_1001042","MONDO_0007576","EFO_0007535","MONDO_0005499","EFO_1001961","EFO_1001471","MONDO_0002120","EFO_0008549","EFO_0002517","EFO_0000702","MONDO_0002367","MONDO_0018906","MONDO_0019004","MONDO_0024880","EFO_0000519","MONDO_0044926","MONDO_0003060","EFO_0003869","MONDO_0000873","MONDO_0016167","EFO_0001075","MONDO_0045056","MONDO_0000956","EFO_1000657","EFO_0000565","EFO_0000309","EFO_0006732","EFO_0000182","MONDO_0005411","MONDO_0020634","EFO_1000785","EFO_0000364","MONDO_0003000","EFO_0001416","MONDO_0001852","EFO_1000606","EFO_0000197","EFO_1000292","MONDO_0021321","EFO_0000248","MONDO_0008170","EFO_0005842","MONDO_0004669","EFO_0002939","EFO_0000502","EFO_0009708","MONDO_0015917","EFO_1000407","EFO_0001061","MONDO_0044787","MONDO_0000386","EFO_0005537","EFO_1001051","MONDO_0019471","EFO_0002938","MONDO_0044964","MONDO_0004192","MONDO_0044887","MONDO_0003196","EFO_1000475","EFO_1001469","MONDO_0021063","MONDO_0002087","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000218","EFO_1001013","MONDO_0001475","EFO_0006352","EFO_0003860","MONDO_0001657","EFO_1000158","EFO_0000437","EFO_0000503","EFO_0000478","EFO_0000313","EFO_0002501","MONDO_0016717","EFO_0004243","MONDO_0021038","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000095","EFO_0000174","EFO_0004142","MONDO_0003219","EFO_1000895","EFO_0003833","EFO_0000691","MONDO_0021637","MONDO_0001325"],"count":152},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for neoplasm and cancer and has 79 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL482505","canonicalSmiles":"CCCCCCC(=O)OC[C@H](COP(=O)(O)O)OC(=O)CCCCCC","inchiKey":"JAXUAGQDLYDLQB-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL482505","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08376"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492513","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1ccc2ccccc2c1","inchiKey":"LVLHTGJPIBVDTM-ZVBGSRNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL492513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06949"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497478","canonicalSmiles":"Cl.O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl","inchiKey":"PAOFPNGYBWGKCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL497478","maximumClinicalTrialPhase":0,"parentId":"CHEMBL445813","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500468","canonicalSmiles":"CCCCCCCC(=O)OC[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"JSRSZGUKOAXAJV-MXAPAKLGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GHRELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ghrelin","Human ghrelin","Lenomorelin"],"count":5,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL502620","canonicalSmiles":"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC","inchiKey":"USZYSDMBJDPRIF-SVEJIMAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACLARUBICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aclacinomycin a","Aclarubicin","Aclarubicin hydrochloride","NSC-208734"],"crossReferences":{"drugbank":["DB11617"],"chEBI":["77980"]},"childChemblIds":["CHEMBL1697719"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL503075","canonicalSmiles":"CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O","inchiKey":"FHNIYFZSHCGBPP-ABBMIVAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Methyl Beta-D-Lactoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Beta-D-Lactoside"],"crossReferences":{"drugbank":["DB04681"],"chEBI":["610092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL513","canonicalSmiles":"O=NN(CCCl)C(=O)NCCCl","inchiKey":"DLGOEMSEDOSKAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMUSTINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicnu","Gliadel"],"synonyms":["BCNU","Carmustine","DTI-015","FDA-0345","NSC-409962","SK-27702","SRI-1720"],"crossReferences":{"DailyMed":["carmustine"],"PubChem":["11110902","124879537","144203648","170464880","174007319","26747453","26753530","479311","50105925","57264377","85230955","90341293"],"Wikipedia":["Carmustine"],"drugbank":["DB00262"],"chEBI":["3423"]},"count":44,"approvedIndications":["EFO_0000616","EFO_0002939","EFO_0001378","EFO_0000183","EFO_0002499","EFO_0000272","EFO_0000519"],"linkedTargets":{"rows":["ENSG00000104687"],"count":1},"linkedDiseases":{"rows":["EFO_0007498","EFO_0000756","MONDO_0044887","EFO_1001465","MONDO_0007254","EFO_0002913","EFO_1001469","EFO_0005952","EFO_0000305","EFO_0000272","EFO_1001951","EFO_0000565","EFO_0000096","HP_0001871","MONDO_0003268","EFO_0000389","MONDO_0001657","EFO_0000326","EFO_0002499","EFO_0000183","EFO_0004991","EFO_1000785","EFO_1000158","EFO_0000616","MONDO_0008170","EFO_0000403","EFO_1000157","EFO_0002939","EFO_0003929","EFO_0002501","EFO_0002500","EFO_0009538","EFO_0000621","MONDO_0008315","EFO_1001383","EFO_0000211","MONDO_0015917","EFO_0000095","EFO_0006475","EFO_0000574","EFO_0004256","EFO_1001051","EFO_0001378","MONDO_0018906","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0024880"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 7 approved and 37 investigational indications."}
{"id":"CHEMBL514988","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1cccnc1","inchiKey":"PYVJEAZDEZTGIS-UBKPWBPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL514988","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL52609","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"IQFYYKKMVGJFEH-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-21548","Thymidin","Thymidine","Thymidinedeoxyriboside","Zidovudine related compound d","Zidovudine related compound d rs"],"crossReferences":{"PubChem":["144205113","29215196"],"Wikipedia":["Thymidine"],"drugbank":["DB04485"],"chEBI":["17748"]},"childChemblIds":["CHEMBL2067985"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL541","canonicalSmiles":"O=C(O)c1ccccc1","inchiKey":"WPYMKLBDIGXBTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Whitfield's"],"synonyms":["Benzoate","Benzoic Acid","Benzoic acid","E210"],"crossReferences":{"PubChem":["144209601","144210500","17390022"],"Wikipedia":["Benzoic_acid"],"drugbank":["DB03793"],"chEBI":["30746"]},"count":1,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for urinary tract infection."}
{"id":"CHEMBL563646","canonicalSmiles":"CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1","inchiKey":"WOHRHWDYFNWPNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVATANEPAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-533,536","CP-533536","Evatanepag"],"crossReferences":{"drugbank":["DB12022"]},"childChemblIds":["CHEMBL2105672"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL574738","canonicalSmiles":"CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1","inchiKey":"ODPGGGTTYSGTGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AST-487","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AST-487","Ast-487","NVP-AST487"],"crossReferences":{"PubChem":["103905682","50100088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL592","canonicalSmiles":"CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13","inchiKey":"JAQUASYNZVUNQP-USXIJHARSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVORPHANOL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IDS-NL-007","Levorphanol","RO 1-5431"],"crossReferences":{"DailyMed":["levorphanol%20tartrate"],"Wikipedia":["Levorphanol"],"drugbank":["DB00854"],"chEBI":["6444"]},"childChemblIds":["CHEMBL1628243","CHEMBL2062261","CHEMBL3989768","CHEMBL3249801"],"count":1,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL606","canonicalSmiles":"CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC","inchiKey":"OJLOPKGSLYJEMD-URPKTTJQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MISOPROSTOL","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytotec","Misoprostol","Mysodelle","Topogyne"],"synonyms":["Misoprostol","SC-29333"],"crossReferences":{"DailyMed":["misoprostol"],"PubChem":["11532984","144205563","26755780","26755781"],"Wikipedia":["Misoprostol"],"drugbank":["DB00929"]},"count":21,"approvedIndications":["HP_0004398","MP_0001914","EFO_0003948","EFO_0002506"],"linkedTargets":{"rows":["ENSG00000050628"],"count":1},"linkedDiseases":{"rows":["EFO_1000874","EFO_1001255","EFO_0003898","EFO_0009846","HP_0000132","EFO_0009579","EFO_0001073","EFO_0003843","MONDO_0000931","EFO_0002950","EFO_0000546","MP_0001914","EFO_0009454","EFO_0003948","HP_0004398","EFO_0002506","HP_0001788","EFO_0000544","EFO_0000731","MONDO_0004247","EFO_1001799","MONDO_0001572","EFO_0003917","MONDO_0001641","EFO_0000668","EFO_1001491","EFO_0001062"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 4 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL628","canonicalSmiles":"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"BYPFEZZEUUWMEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOXIFYLLINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neotren mr","Pentoxifylline","Pentoxil","Trental","Trental 100","Trental 400"],"synonyms":["BL 191","BL-191","C04AD03","NSC-637086","Oxpentifylline","Pentoxifylline"],"crossReferences":{"DailyMed":["pentoxifylline"],"PubChem":["11111613","11111614","124881066","144203774","170465384","26719692","26747196","50085870","50105176","85231180","857899","90341235"],"Wikipedia":["Pentoxifylline"],"drugbank":["DB00806"],"chEBI":["7986"]},"count":42,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000185527","ENSG00000139053","ENSG00000152270","ENSG00000128271","ENSG00000105650","ENSG00000154678","ENSG00000112541","ENSG00000132915","ENSG00000172572","ENSG00000160191","ENSG00000123360","ENSG00000171408","ENSG00000205268","ENSG00000115252","ENSG00000073417","ENSG00000133256","ENSG00000170425","ENSG00000065989","ENSG00000095464","ENSG00000113448","ENSG00000186642","ENSG00000113231","ENSG00000138735","ENSG00000156973","ENSG00000184588"],"count":25},"linkedDiseases":{"rows":["Orphanet_30391","MONDO_0018373","HP_0001397","EFO_0003869","EFO_1001346","EFO_0000278","EFO_0007444","MONDO_0002009","EFO_0003780","EFO_0000555","EFO_0000401","HP_0001643","DOID_13406","EFO_1001249","EFO_0001065","MONDO_0002462","EFO_1001345","EFO_1001486","EFO_1001821","EFO_0000289","HP_0040187","EFO_0006890","EFO_0003884","EFO_0005046","EFO_0004255","EFO_1000652","EFO_0004272","EFO_0000692","EFO_1000158","EFO_0005761","EFO_0005774","EFO_0000545","EFO_0003928","EFO_0005044","EFO_0000220","EFO_1000844","HP_0001919","EFO_0001645","EFO_0000319","EFO_0001073","EFO_0000384","EFO_0003060","EFO_0000311","Orphanet_98896","HP_0001399","EFO_0001422","EFO_0000546","MONDO_0100096","EFO_0000764","EFO_0004284","EFO_0001360","EFO_0005672"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for cardiovascular disease and has 41 investigational indications."}
{"id":"CHEMBL70971","canonicalSmiles":"COC(=O)Nc1nc2ccccc2[nH]1","inchiKey":"TWFZGCMQGLPBSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENDAZIM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A 118","BAS-67054F","Bavistin","Carbendazim","EK-578","FB-642","Fenbendazole related compound a","NSC-109874"],"crossReferences":{"PubChem":["144209493","144210796","17389123","26752754","408937","92763967"],"Wikipedia":["Carbendazim"],"drugbank":["DB13009"],"chEBI":["3392"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL748","canonicalSmiles":"C[n+]1ccccc1/C=N/O.[Cl-]","inchiKey":"HIGSLXSBYYMVKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALIDOXIME CHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1420","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["2-Pam","Contrathion","Duodote","Pralidoxime chloride","Pralidoxime chloride (autoinjector)","Protopam","Protopam chloride"],"synonyms":["2-PAM","2-PAM CHLORIDE","2-PAM Chloride","Pralidoxime chloride"],"crossReferences":{"DailyMed":["pralidoxime%20chloride"],"PubChem":["11533058","144203867","170465059","56422221"],"chEBI":["8355"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964."}
{"id":"CHEMBL760","canonicalSmiles":"O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1","inchiKey":"OTBXOEAOVRKTNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAGRELIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Agrylin","Anagrelide","Xagrid"],"crossReferences":{"DailyMed":["anagrelide%20hydrochloride"],"PubChem":["124892336","26755034"],"Wikipedia":["Anagrelide"],"drugbank":["DB00261"],"chEBI":["142290"]},"childChemblIds":["CHEMBL1200759"],"count":4,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000152270","ENSG00000172572"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004251","HP_0004419","EFO_0002429","EFO_0000479"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for neoplasm and has 3 investigational indications."}
{"id":"CHEMBL785","canonicalSmiles":"C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1","inchiKey":"IOVGROKTTNBUGK-SJCJKPOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITODRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ritodrine"],"crossReferences":{"Wikipedia":["Ritodrine"],"drugbank":["DB00867"],"chEBI":["8872"]},"childChemblIds":["CHEMBL1201160"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL803","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1","inchiKey":"UHDGCWIWMRVCDJ-CCXZUQQUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CYTARABINE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-cytidine","Arabinosyl cytosine","Cytarabine","NSC-287459","U-19,920","U-19920"],"crossReferences":{"DailyMed":["cytarabine"],"PubChem":["131404637","144204754","144212288","26719755","29215144","47193873","90341066"],"Wikipedia":["Cytarabine"],"drugbank":["DB00987"],"chEBI":["28680"]},"childChemblIds":["CHEMBL1256472"],"count":74,"approvedIndications":["EFO_0000616","MONDO_0000873","EFO_0003028","EFO_0000220","MONDO_0000870","EFO_0000222","EFO_0003027","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000062822","ENSG00000146143","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":11},"linkedDiseases":{"rows":["EFO_1001257","MONDO_0000873","EFO_0004708","EFO_0000756","EFO_1000131","EFO_0005952","EFO_1001052","EFO_0000565","EFO_0000309","EFO_1000318","EFO_0004251","EFO_1001935","EFO_0000339","EFO_0000096","EFO_0002690","MONDO_0019088","MONDO_0019460","EFO_0000330","EFO_0004991","EFO_0000094","EFO_0000198","EFO_0000221","EFO_0003802","EFO_0000220","EFO_1000823","EFO_0002508","MONDO_0008170","EFO_1000157","EFO_0000223","EFO_1000286","EFO_1001946","EFO_1000309","EFO_0002939","MONDO_0044881","EFO_0000224","EFO_0002429","EFO_0003025","EFO_0009538","MONDO_0008315","EFO_1001365","EFO_0003028","MONDO_0044889","EFO_0003032","EFO_0003851","MONDO_0044917","EFO_0002428","EFO_0000574","EFO_0004256","EFO_0001378","EFO_0000218","EFO_1002001","MONDO_0009348","MONDO_0044903","MONDO_0019471","EFO_0003812","EFO_0007498","MONDO_0044887","MONDO_0007254","EFO_1001945","EFO_1001469","EFO_0000209","MONDO_0003541","EFO_0003882","MONDO_0001475","EFO_0004289","MONDO_0004695","EFO_0000183","MONDO_0020743","EFO_0010580","MONDO_0002083","EFO_1000158","EFO_0000479","EFO_0000616","EFO_1001779","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0003929","EFO_0003029","EFO_1001383","EFO_0000311","EFO_1001934","EFO_0000211","EFO_0001068","EFO_0000095","EFO_0006475","EFO_1001936","EFO_1001947","EFO_1000781","MONDO_0018906","EFO_0004191","EFO_0000691","EFO_0000519","EFO_0003027","EFO_0003811"],"count":96},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 8 approved and 66 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL82767","canonicalSmiles":"NCCNc1cc(-c2ccc[nH]2)c2c3c(ccc(F)c13)NC2=O","inchiKey":"CQCXWWWNUFQYJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL82767","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07163"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87223","canonicalSmiles":"Cc1cc(N)c2cc(NC(=O)Nc3ccc4nc(C)cc(N)c4c3)ccc2n1","inchiKey":"HOUSDILKOJMENG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOQUINURIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminoquinuride"],"crossReferences":{"PubChem":["104171089","4252577","50107933","50107934"],"drugbank":["DB04452"]},"childChemblIds":["CHEMBL1965412","CHEMBL2132372"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL88611","canonicalSmiles":"Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O","inchiKey":"RYIGNEOBDRVTHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-CHLOROTHEOPHYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Chlorotheophylline"],"crossReferences":{"Wikipedia":["8-Chlorotheophylline"],"drugbank":["DB14132"],"chEBI":["59771"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL978","canonicalSmiles":"CC(=O)OC(C)C[N+](C)(C)C","inchiKey":"NZWOPGCLSHLLPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHACHOLINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methacholine","Provocholine"],"crossReferences":{"DailyMed":["methacholine%20chloride"],"PubChem":["90340728"],"Wikipedia":["Methacholine"],"drugbank":["DB06709"],"chEBI":["6804"]},"childChemblIds":["CHEMBL1200764","CHEMBL12137","CHEMBL2106885"],"count":1,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL991","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"XNKLLVCARDGLGL-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STAVUDINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Stavudine","Zerit","Zerit xr"],"synonyms":["BMY-27857","D-4T","D4T","NSC-163661","Sanilvudine","Stavudine","Zerit","d4T"],"crossReferences":{"DailyMed":["stavudine"],"PubChem":["144208591","144210900","170464820","17389053","17389074","26719688","26751536","29215013","49718181","50104116","50104117","56422159","7971664","855856","90341632"],"Wikipedia":["Stavudine"],"drugbank":["DB00649"],"chEBI":["63581"]},"count":6,"approvedIndications":["EFO_0000764","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for hiv infection and viral disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL99965","canonicalSmiles":"Cc1occc1C(=S)Nc1ccc(Cl)c(/C=N/OC(C)(C)C)c1","inchiKey":"PLGIIOKXCKDKEU-VXLYETTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL99965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["502348"],"drugbank":["DB08680"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
